CombiMatrix Molecular Diagnostics Launches Microarray Test for Detection of Autism Spectrum Disorder
Posted Sep 29 2008 10:45pm
CombiMatrix has completed the clinical validation of the BAC array CGH based clinical microarray tests. ATScan is designed to detect known genomic copy-number variations associated with Autism Spectrum Disorder and this test is now available to physicians and consumers.
CombiMatrix has completed the clinical validation of the BAC array CGH based clinical microarray tests. ATScan is designed to detect known genomic copy-number variations associated with Autism Spectrum Disorder and this test is now available to physicians and consumers.
Filed under: Clinical microarrays, Next Generation of DNA and RNA Microarrays, Pharmacogenomics, microarray blog, microarray for clinical diagnostics, personalized medicine